PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day - Seite 2

 

 

 

“PPD is passionate about making a difference in the lives of people living with rare diseases,” said Wendy Buckland, vice president of PPD’s neuroscience global therapeutic unit. “In the pandemic, Rare Disease Day looks different this year, but PPD is committed to raising awareness in this complex space, and our hope is that the building illumination at our worldwide headquarters will reflect our dedication to helping deliver life-changing therapies for patients around the globe. Throughout the pandemic and across the company, PPD has been able to implement the right solutions, such as tele-visits, to make it easier for people to participate in clinical trials for both rare disease and non-rare disease patients, and that is vital in getting new medicines to market.”

 

 

 

For more information on Rare Disease Day, please visit https://rarediseases.org/rare-disease-day.

 

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppd.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210226005401/en/